James Gosnell

Papers

1

Total Citations

17

H-Index

1

About

James Gosnell is a clinical researcher whose work centers on perioperative pain management and surgical outcomes, with a particular focus on urological oncology procedures. His most notable contribution is a landmark 2018 study published in *Urology*, a prospective, randomized, double-blind, placebo-controlled trial evaluating the efficacy of intravenous acetaminophen in patients undergoing robotic-assisted laparoscopic prostatectomy (RALP). This work, which has garnered 17 citations, directly addressed a critical gap in postoperative care for one of the most common surgeries in men—radical prostatectomy for prostate cancer. By rigorously testing whether adding IV acetaminophen to standard analgesic regimens could improve recovery, Gosnell provided evidence-based insights that help reduce opioid reliance and enhance patient comfort after RALP. His research exemplifies the integration of rigorous clinical trial methodology into surgical practice, offering tangible improvements in pain management protocols. Through this focused investigation, Gosnell has contributed to advancing perioperative care in urologic oncology, demonstrating how targeted, high-quality studies can shape clinical guidelines and improve outcomes for patients undergoing major cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Intravenous Acetaminophen Versus Placebo in Patients Undergoing Robotic-Assisted Laparoscopic Prostatectomy
17 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago